Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

NCT03119857 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

349

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms

Interventions

DRUG: Antiandrogen
DRUG: Antiandrogen+docetaxel

Sponsor

Göteborg University

Collaborators

[object Object]